Capital Fund Management (CFM)
KYNB

Capital Fund Management (CFM)’s Kyntra Bio KYNB Stock Holding History

Capital Fund Management (CFM)’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-216
Closed -$338K – 2058
2018
Q2 		$338K Buy
+216
New +$282K ﹤0.01% 1746

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Fund Management (CFM)'s KYNB Position: Q3 2021 in Review

Capital Fund Management (CFM) sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 411 shares — an estimated $274K sold.

Capital Fund Management (CFM) first reported a position in KYNB in Q2 2016 and held it in 7 quarters. The position peaked at $1.2M in Q2 2020. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

  • Capital Fund Management (CFM) reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 411 Kyntra Bio shares in Q3 2021, an estimated $274K.
  • Capital Fund Management (CFM) first reported a position in Kyntra Bio in Q2 2016 and held it in 7 quarters.
  • Capital Fund Management (CFM)'s Kyntra Bio position peaked at $1.2M in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2021, filed 12 Nov 2021.